ArticleInfectious diseases and therapy2024

Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States.

Daniel Molnar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.